Doctors at Nuneaton’s George Eliot Hospital are calling for adult volunteers with type 1 Diabetes to help with a research project that tests a new type of tablet taken in addition to insulin.
George Eliot Hospital is one of 135 clinics and hospitals across the globe that is involved in a trial of the drug Empagliflozin for treating high blood glucose in Type 1 Diabetes.
The purpose of this research study is to determine if Empagliflozin is effective as an ‘add on’ tablet treatment in addition to insulin, in the treatment of Type 1 diabetes. This tablet is already been used in Type 2 diabetic patients.
The trial will last approximately 64 weeks and volunteers will be closely monitored. As a minimum, volunteers will have 16 visits to the study clinic, and one visit that will be done over the telephone. Each visit will take 1-2 hours to complete, depending on what has to be done. Travel expenses will be reimbursed.
The Doctor leading the research, Dr. Ponnusamy Saravanan said: “We’re looking for volunteers who take insulin through daily injections or an insulin pump. We will carefully screen all participants to make sure they are suitable and they will be monitored throughout.”
People who consider themselves suitable are being asked to call the hospital’s Diabetes Research Team on 02476 153592.